Delivery Order SPE2DB22D1106-SPE2DB25FELU5

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,626.85 firm fixed-price contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a prescription medication. The contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $53,721.46, is for the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and...
This is a $116,388.29 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with TRIUMEQ 600-50-300 MG TABLET, a specialty pharmaceutical product, through January 27, 2025. This award is a task order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,593.36, covers the delivery of TRIUMEQ 600-50-300 MG TABLET in quantities of 30s. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 6, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $100,120.62, is for the delivery of TRIUMEQ 600-50-300 MG TABLET in 30-count packages. The contract has a period of performance through March 21, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a prescription medication, with a ceiling value of $13,455.55. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which has an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,765.65 firm fixed price contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a period of performance through March 10, 2025. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,080.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication, with an ultimate completion date of June 14, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,193.85, is for the supply of TRIUMEQ 600-50-300 MG TABLET medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a ceiling value of $9,620.51 and a completion date of January 9, 2025. The contract is a firm fixed-price delivery order, indicating the government has pre-determined the unit price for the pharmaceutical item. There is no set-aside...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FELU5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,034.32, is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a prescription medication. The contract is a firm fixed-price delivery order, with a performance period that extends through May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating this was an open competition. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026.

Generated 8/3/25, 1:28 AM